 |
 |
 |
||||||||||||||||||||||||||||||||||||
 |
|
 |
||||||||||||||||||||||||||||||||||||
 |
 |
 |
||||||||||||||||||||||||||||||||||||
It is a controlled, randomized, clinical trial that will recruit 720 women to examine whether estrogen given orally (conjugated equine) or transdermally (skin patch) slows the rate of hardening of the arteries (atherosclerosis).
Home |
About Us |
KEEPS |
Why KEEPS |
FAQ |
Contact Us
Who We Are |
Governance |
Board of Directors |
Mission |
Staff |
Principal Investigators Roster
Press Releases |
What is KEEPS? |
Why KEEPS? |
Study Overview |
KEEPS Planning Consortium |
Cardiovascular Disease
Estrogen |
Stroke |
Fractures |
KEEPS |
Hormone Replacement Therapy |
General Information Request
Copyright 2006 Early
Estrogen Prevention Study. All rights reserved.
[ Sponsored by Kronos Longevity Research Institute ]